1Prince, M, Ali, GC, Guerchet, M, Yu-Tzu, W, Prina, M. The global prevalence of dementia. In World Alzheimer Report 2015 (eds G Rees, S Fletcher): 10–29. Alzheimer's Disease International, 2015.
2O'Brien, JT, Thomas, A. Vascular dementia. Lancet 2015; 386: 1698–706.
3Fiest, KM, Roberts, JI, Maxwell, CJ, Hogan, DB, Smith, EE, Frolkis, A, et al. The prevalence and incidence of dementia due to Alzheimer's disease: a systematic review and meta-analysis. Can J Neurol Sci 2016; 43(Suppl 1): S51–82.
4Rizzi, L, Rosset, I, Roriz-Cruz, M. Global epidemiology of dementia: Alzheimer's and vascular types. BioMed Res Int 2014; 2014: 1–8.
5Gulpers, B, Ramakers, I, Hamel, R, Kohler, S, Oude Voshaar, R, Verhey, F. Anxiety as a predictor for cognitive decline and dementia: a systematic review and meta-analysis. Am J Geriatr Psychiatry 2016; 24: 823–42.
6Machado, A, Herrera, AJ, de Pablos, RM, Espinosa-Oliva, AM, Sarmiento, M, Ayala, A, et al. Chronic stress as a risk factor for Alzheimer's disease. Rev Neurosci 2014; 25: 785–804.
7Pary, R, Matuschka, PR, Lewis, S, Caso, W, Lippmann, S. Generalized anxiety disorder. South Med J 2003; 96: 581–6.
8Fuxe, K, Diaz, R, Cintra, A, Bhatnagar, M, Tinner, B, Gustafsson, J-A, et al. On the role of glucocorticoid receptors in brain plasticity. Cell Mol Neurobiol 1996; 16: 239–58.
9Dubois, B, Epelbaum, S, Santos, A, Di Stefano, F, Julian, A, Michon, A, et al. Alzheimer disease: from biomarkers to diagnosis. Rev Neurol 2013; 169: 744–51.
10Prenderville, JA, Kennedy, PJ, Dinan, TG, Cryan, JF. Adding fuel to the fire: the impact of stress on the ageing brain. Trends Neurosci 2015; 38: 13–25.
11Moher, D, Liberati, A, Tetzlaff, J, Altman, DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
12Stroup, DF, Berlin, JA, Morton, SC, Olkin, I, Williamson, GD, Rennie, D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008–12.
13Higgins, JPT, Green, S (ed). Cochrane Handbook for Systematic Reviews of Interventions: Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011.
14American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. American Psychiatric Publishing, 2013.
15Sartorius, N. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines: 47–51. World Health Organization, 2016.
16Gough, D. Weight of evidence: a framework for the appraisal of the quality and relevance of evidence. Res Pap Educ 2007; 22: 213–28.
17Wells, GA, Shea, B, O'Connell, D, Peterson, J, Welch, V, Losos, M, et al. The Newcastle Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-Analyses. Ottawa Hospital Research Institute, 2014. (http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp).
18Sterne, JA, Hernán, MA, Reeves, BC, Savović, J, Berkman, ND, Viswanathan, M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016; 355: i4919.
19Schwarzer, G, Carpenter, JR, Rücker, G. Chapter 2, Fixed effects and random effect meta-analysis. In Meta-Analysis with R: 28–40. Springer International Publishing, 2015.
20Schwarzer, G, Carpenter, JR, Rücker, G. Chapter 2.6.1, meta-analysis with survival outcomes. In Meta-Analysis with R (eds R Gentleman, K Hornik, G Parmigiani): 46–8. Springer International Publishing, 2015.
21R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, 2017 (https://www.R-project.org/).
22Schwarzer, G. meta: an R package for meta-analysis. R News 2007; 7: 40–5.
23Burke, SL, Maramaldi, P, Cadet, T, Kukull, W. Neuropsychiatric symptoms and apolipoprotein E: associations with eventual Alzheimer's disease development. Arch Gerontol Geriatr 2016; 65: 231–8.
24Burke, SL, O'Driscoll, J, Alcide, A, Li, T. Moderating risk of Alzheimer's disease through the use of anxiolytic agents. Int J Geriatr Psychiatry 2017; 32: 1312–21.
25Bruijn, RF, Direk, N, Mirza, SS, Hofman, A, Koudstaal, PJ, Tiemeier, H, et al. Anxiety is not associated with the risk of dementia or cognitive decline: the Rotterdam Study. Am J Geriatr Psychiatry 2014; 22: 1382–90.
26Gallacher, J, Bayer, A, Fish, M, Pickering, J, Pedro, S, Dunstan, F, et al. Does anxiety affect risk of dementia? Findings from the Caerphilly Prospective Study. Psychosom Med 2009; 71: 659–66.
27Jessen, F, Wolfsgruber, S, Wiese, B, Bickel, H, Mosch, E, Kaduszkiewicz, H, et al. AD dementia risk in late MCI, in early MCI, and in subjective memory impairment. Alzheimers Dement 2014; 10: 76–83.
28Lobo, A, Bueno-Notivol, J, de La Camara, C, Santabarbara, J, Marcos, G, Gracia-Garcia, P, et al. Clinically relevant anxiety and risk of dementia and Alzheimer's disease. J Psychosom Res 2017; 97: 158–9.
29Palmer, K, Berger, AK, Monastero, R, Winblad, B, Bäckman, L, Fratiglioni, L. Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology 2007; 68: 1588–602.
30Stewart, JC, Perkins, AJ, Hendrie, HC, Callahan, CM. Depression and anxiety screens as predictors of 8-year incidence of total dementia, Alzheimer's disease, and vascular dementia. Psychosom Med 2015; 77: A3.
31Terracciano, A, Sutin, AR, An, Y, O'Brien, RJ, Ferrucci, L, Zonderman, AB, et al. Personality and risk of Alzheimer's disease: new data and meta-analysis. Alzheimers Dement 2014; 10: 179–86.
32Wilson, RS, Begeny, CT, Boyle, PA, Schneider, JA, Bennett, DA. Vulnerability to stress, anxiety, and development of dementia in old age. Am J Geriatr Psychiatry 2011; 19: 327–34.
33Zilkens, RR, Bruce, DG, Duke, J, Spilsbury, K, Semmens, JB. Severe psychiatric disorders in mid-life and risk of dementia in late-life (age 65-84 years): a population based case-control study. Curr Alzheimer Res 2014; 11: 681–93.
34Dondu, A, Sevincoka, L, Akyol, A, Tataroglu, C. Is obsessive–compulsive symptomatology a risk factor for Alzheimer-type dementia? Psychiatry Res 2015; 225: 381–6.
35Diniz, BS, Butters, MA, Albert, SM, Dew, MA, Reynolds, CF III. Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry 2013; 202: 329–35.
36Tapiainen, V, Hartikainen, S, Taipale, H, Tiihonen, J, Tolppanen, A-M. Hospital-treated mental and behavioral disorders and risk of Alzheimer's disease: a nationwide nested case-control study. Eur Psychiatry 2017; 43: 92–8.
37Kuiper, JS, Zuidersma, M, Oude Voshaar, RC, Zuidema, SU, van den Heuvel, ER, Stolk, RP, et al. Social relationships and risk of dementia: a systematic review and meta-analysis of longitudinal cohort studies. Ageing Res Rev 2015; 22: 39–57.
38Steunenberg, B, Twisk, JWR, Beekman, ATF, Deeg, DJH, Kerkhof, AJFM. Stability and change of neuroticism in aging. J Gerontol B Psychol Sci Soc Sci 2005; 60: P27–33.
39Beauquis, J, Vinuesa, A, Pomilio, C, Pavia, P, Galvan, V, Saravia, F. Neuronal and glial alterations, increased anxiety, and cognitive impairment before hippocampal amyloid deposition in PDAPP mice, model of Alzheimer's disease. Hippocampus 2014; 24: 257–69.
40Marchant, NL, Howard, RJ. Cognitive debt and Alzheimer's disease. J Alzheimers Dis 2015; 44: 755–70.
41Barulli, D, Stern, Y. Efficiency, capacity, compensation, maintenance, plasticity: emerging concepts in cognitive reserve. Trends Cogn Sci 2013; 17: 502–9.
42McEwen, BS. Stress, adaptation, and disease: allostasis and allostatic load. Ann N Y Acad Sci 1998; 840: 33–44.
43de Lijster, JM, Dierckx, B, Utens, EMWJ, Verhulst, FC, Zieldorff, C, Dieleman, GC, et al. The age of onset of anxiety disorders. Can J Psychiatry 2017; 62: 237–46.
44Bruce, SE, Yonkers, KA, Otto, MW, Eisen, JL, Weisberg, RB, Pagano, M, et al. Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry 2005; 162: 1179–87.
45Whalley, LJ, Dick, FD, McNeill, G. A life-course approach to the aetiology of late-onset dementias. Lancet Neurol 2006; 5: 87–96.
46Watson, D, Clark, LA, Carey, G. Positive and negative affectivity and their relation to anxiety and depressive disorders. J Abnorm Psychol 1988; 97: 346–53.
47do Couto, FS, Lunet, N, Gino, S, Chester, C, Freitas, V, Maruta, C, et al. Depression with melancholic features is associated with higher long-term risk for dementia. J Affect Disord 2016; 202: 220–9.
48Remes, O, Brayne, C, van der Linde, R, Lafortune, L. A systematic review of reviews on the prevalence of anxiety disorders in adult populations. Brain Behav 2016; 6: e00497.
49Esler, M. Mental stress and human cardiovascular disease. Neurosci Biobehav Rev 2017; 74: 269–76.